Search Site

Zilico Limited

Company History


Zilico selected for IFC TechEmerge programme

Finalist in HSJ "Improving Care with Techonology" award category

1500 patient ZedScan case study published

Zilico included in CEBR Medical Device SME hotlist

Zilico appoints new Commercial Director


1000 patient ZedScan case study published

Another Key reference site adopts ZedScan

Steve Couldwell appointed to the Board of Directors

Zilico CEO invited to Downing Street

First hospital in GCC adopts ZedScan into routine use

Prof. John Tidy begins 3 year tenure as BSCCP President

NICE publishes Medical Innovation Briefing on ZedScan

500 patient ZedScan case study published


International distributors appointed

Winner of 2014 Medilink National Award for Partnership with NHS

TGA approval (Australia) of ZedScan cervical cancer diagnostic system

Zilico awarded TSB grant funding for development of oral diagnostic system

ZedScan awarded medical device licence by Health Canada

Oral diagnostic proof of concept study published in International Journal of Nanomedicine

First UK Hospital Trust adopts ZedScan into routine clinical practice

Regulatory approval for ZedScan in Israel

Zilico "Highly Commended" in the 2014 UK NHS Excellence in Supply Awards, NW region.


Zilico appoints GB distributor

Winner of 2013 Bionow award for Best Product or Service of the Year

Company awarded ISO13485

EC certification of cervical cancer diagnostic system- ZedScan

Zilico’s first product, ZedScan, launches in EU

Proof of concept for oral diagnostic data presented at the American Academy of Oral Medicine (AAOM)

Publication of multi-centre study in BJOG, March 2013


Best Scientific Paper Award at ASCCP, San Francisco, USA 

Zilico secures £750K investment from North West Fund for Biomedical managed by Spark Investment


Prof. John Tidy presents preliminary findings from pivotal multi-centre study at EuroGIN, IFCPC and ESCGO conferences

Cervical cancer diagnostic presented at FICCI HEAL , India

Multi-centre clinical trial completed


Zilico secures additional funding


Publication of 2007 study in Gynaecological Oncology Journal


Company secures additional funding to undertake multi-centre clinical trial of cervical cancer diagnostic

Company name changed to Zilico Ltd

Medical Advisory Board established


Zilico appoints Sameer Kothari as CEO


Company founded under the name Aperio Diagnostics


Completion of a further 3 trials


Founders awarded NEAT grant by the NHS


First clinical trial published in The Lancet


Collaboration with Sheffield Teaching Hospitals NHS Foundation Trust to investigate the use of electrical impedance to detect and identify cancerous and precancerous conditions of the cervix


Research by Prof. Brian Brown, University of Sheffield, UK, into the use of electrical impedance for medical applications